Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - MarketIntelReports

1
Irritable Bowel Syndrome-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2016
Published on - 01 January, 2016 Number of
pages 100 Single User Price 2000
Irritable Bowel Syndrome-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2016, provides comprehensive insights
about the marketed drugs, drug sales, Phase III
pipeline drugs and their API Manufacturers across
the globe.
2
A key objective of the Irritable Bowel Syndrome
Report is to understand the market and pipeline
status of the drugs around the Irritable Bowel
Syndrome to explore the generic development
opportunities, licensing opportunities and to
gain competitive advantage on designing pipeline
strategies. The Report provides the historical
and forecasted sales of the drugs till 2018.
The Irritable Bowel Syndrome Report gives
insights into patents providing the patent
protection data and marketing exclusivity of all
the drugs across the Irritable Bowel Syndrome.
While the leading brands, companies and
chemicals are considered thoroughly, the report
also provides details on the Global API
Manufacturers across the globe covering Drug
Master Filings of US, Europe and API
Manufacturers in Asia specifically China and
India.
Click Here To Check Complete Report
3
Scope of Report A snapshot of the global
Market and Phase III therapeutics scenario for
Irritable Bowel Syndrome. A review of the
marketed products under prescription for
Irritable Bowel Syndrome, regulatory
information and marketing status. Coverage of
global patent coverage and detailed commentaries
on the US patent challenges. Graphical
representation of investigational products for
patent expiry and market exclusivities
across the globe. Product profiles for
marketed products for Irritable Bowel Syndrome
with complete description of mechanism of
action, therapeutic class, target, route(s)
of administration and chemical details.
4
Coverage of API Manufacturers for Irritable
Bowel Syndrome drugs in the United States,
Europe and Asian Regions with location details.
Coverage of Regulatory filings in the US,
Europe, and Asia specifically India and
China for Irritable Bowel Syndrome drugs.
Coverage of Route of Synthesis of Active
Pharmaceutical Ingredient associated with
Irritable Bowel Syndrome drugs. Coverage of
Irritable Bowel Syndrome Phase III pipeline
products featuring sections on product
description, mechanism of action, Chemical
details and research development
progress. Coverage of the United States Drug
Master File (US DMF) available for Phase III
Pipeline Drugs. Key discontinued Marketed
products. Global Sales Figure to 2018.
Download Sample Brochure
5
Reasons to buy Evaluate the marketing status
and exclusivity details of Irritable Bowel
Syndrome key products to exploit opportunities
for generic drug development opportunities.
Identify and understand important and diverse
types of therapeutics under Phase III
development for Irritable Bowel Syndrome.
Design effective counter-strategies to gain
competitive advantage by identifying the key
patent expiry details and exclusivity with
respect to Irritable Bowel Syndrome. API
intelligence over marketed drugs for Irritable
Bowel Syndrome and gaining primary
intelligence over active ingredients
manufacturers across the globe. API
intelligence over leading Phase III Pipeline
drugs.
6
Develop and design strategies by identifying
the API manufacturers for Phase III Pipeline
products to enhance and expand business potential
and scope. Understanding the scope of the
Phase III Drugs with nil regulatory filings.
Understanding the chemical route of synthesis of
approved drugs for Irritable Bowel
Syndrome. Uncovering opportunities in the
rapidly growing US market.
Make an Inquiry Before Buying
7
The Global Unmanned Aerial Vehicle Market
2015-2025 - Competitive Landscape and Strategic
Insights Market Profile
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
Irritable Bowel Syndrome-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2016 and future opportunities are
provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Irritable Bowel
Syndrome Market Report